MHRA approves licence 8th August 2018

08 Aug MHRA approves licence 8th August 2018

Posted at 11:49h in News by

Biotherapy Services Limited

 

MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment.

 

Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018

 

For further information, please contact:

Biotherapy Services Ltd

Janet Hadfield, Chief Executive Officer

Info@lisat86.sg-host.comTel: ++44 (0) 207 788 7828

 

Print page